Sitravatinib in combination with nivolumab demonstrates clinical activity in platinum-experienced patients with urothelial carcinoma (UC) who progressed on prior immune checkpoint inhibitor (CPI) Meeting Abstract


Authors: Msaouel, P.; Siefker-Radtke, A.; Sweis, R.; Mortazavi, A.; Vogelzang, N.; Vaishampayan, U.; Bradley, T.; Bupathi, M.; Nordquist, L.; Shaffer, D.; Picus, J.; Yorio, J.; Mao, S.; Doshi, G.; Spitz, D.; Gandhi, S.; Chong, D.; Kalebasty, A. R.; Christensen, J.; Olson, P.; Faltaos, D.; Shazer, R.; Winter, M.; Alvarez, D.; Del-Torossian, H.; Rosenberg, J.
Abstract Title: Sitravatinib in combination with nivolumab demonstrates clinical activity in platinum-experienced patients with urothelial carcinoma (UC) who progressed on prior immune checkpoint inhibitor (CPI)
Meeting Title: 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 7
Issue: Suppl. 1
Meeting Dates: 2019 Nov 6-10
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2019-11-01
Start Page: 283
Language: English
ACCESSION: WOS:000496473200368
PROVIDER: wos
PMCID: PMC6833180
PUBMED: 31694708
DOI: 10.1186/s40425-019-0764-0
Notes: Meeting Abstract: O23 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg